<DOC>
	<DOCNO>NCT00361309</DOCNO>
	<brief_summary>The main purpose study begin collect information try learn whether SU011248 work treat patient advanced liver cancer . Laboratory study show SU011248 may block growth blood vessel tumor , may prevent tumor grow .</brief_summary>
	<brief_title>SU011248 Advanced Hepatocellular Carcinoma</brief_title>
	<detailed_description>- Participants give supply SU011248 capsule take orally every morning 4 week . After take SU011248 4 week , 2 week rest period participant take capsule . This 6-week period refer 1 cycle . - Participants continue receive SU011248 study treatment long disease worsen significantly experience serious side effect . - During cycle 1 study treatment , participant come outpatient clinic week blood work , physical examination dynamic contrast enhance magnetic resonance imaging ( DCE-MRI ) , do two week start take study treatment . - During cycle two every cycle thereafter , participant ask come outpatient clinic every two week physical examination , blood work urine test . - A CT scan MRI scan ass tumor perform cycle first three cycle , every 2 cycle thereafter . ACTH stimulation test do every 2 cycle . A MUGA scan may do anytime discretion study doctor .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<mesh_term>Liver Neoplasms</mesh_term>
	<mesh_term>Sunitinib</mesh_term>
	<criteria>Histologically cytologically confirm HCC metastatic locally advanced unresectable disease Measurable disease 01 prior systemic chemotherapy regimens HCC Age 18 year old Life expectancy great 12 week ECOG performance status 01 Adequate organ marrow function Women childbearing potential must negative pregnancy test prior study entry Chemotherapy , radiotherapy major surgery within 4 week study entry Receiving investigational agent within past 30 day Known brain metastasis CLIP score &gt; 3 Chronic diarrhea disorder limit adequate absorption SU011248 Prolongation QTc &gt; 450 msec screen electrocardiogram history familial long QT syndrome Uncontrolled intercurrent illness Pregnant lactate woman Greater equal 2g protein/24hr</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2014</verification_date>
	<keyword>liver cancer</keyword>
	<keyword>HCC</keyword>
</DOC>